Taipei, Taiwan

Cheng-Hsun Wu

USPTO Granted Patents = 6 


Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Tuinan, TW (1988)
  • New Taipei, TW (2017 - 2022)
  • Zhubei, TW (2024)

Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Cheng-Hsun Wu: Innovator in Nanotechnology and Cancer Treatment

Introduction

Cheng-Hsun Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of nanotechnology, particularly in the development of innovative solutions for cancer treatment. With a total of 6 patents to his name, Wu's work is at the forefront of medical advancements.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastases." This patent focuses on a method that utilizes mesoporous silica nanoparticles (MSNs) loaded with taxane-based chemotherapeutic drugs, specifically paclitaxel (PTX), cabazitaxel (CTX), or docetaxel (DTX), to effectively prevent or treat brain cancers. Another notable patent is "Silica nanosphere for immunotherapy," which explores the use of hollow silica nanospheres as adjuvants to enhance immune responses or as carriers for antigen delivery within the body.

Career Highlights

Cheng-Hsun Wu has worked with various companies, including Nano Targeting & Therapy Biopharma Inc. His innovative research and development efforts have positioned him as a key figure in the biopharmaceutical industry, particularly in the realm of cancer therapies.

Collaborations

Wu has collaborated with notable colleagues, including Si-Han Wu and Chung-Yuan Mou, contributing to the advancement of research in nanotechnology and its applications in medicine.

Conclusion

Cheng-Hsun Wu's contributions to nanotechnology and cancer treatment exemplify the impact of innovative thinking in addressing critical health challenges. His patents reflect a commitment to improving therapeutic options for patients suffering from brain cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…